诊断时年龄对2型糖尿病与癌症发病及死亡关联的影响:一项回顾性匹配队列研究
基于鄞州健康信息系统42,279例2010至2014年新诊断2型糖尿病患者及166,010名年龄性别匹配的无糖尿病对照,按诊断年龄分层分析。中位随访9.20和9.32年期间,诊断年龄<50岁者癌症发病和死亡相对风险最高,总体癌症发病HR为1.35(95%CI 1.20, 1.52),总体癌症死亡HR为2.02(95%CI 1.50, 2.71)。风险估计随诊断年龄每增加10岁而逐渐降低。
要点
- 诊断年龄<50岁的2型糖尿病患者总体癌症发病HR为1.35(95%CI 1.20, 1.52)。
- 诊断年龄<50岁者总体癌症死亡HR为2.02(95%CI 1.50, 2.71)。
- 2型糖尿病与癌症发病和死亡的关联随诊断年龄增大而减弱。
核心结论
- 2型糖尿病与癌症发病和死亡的关联因诊断年龄而异,较年轻诊断者的相对风险更高。
研究设计与样本
- 回顾性匹配队列研究,使用鄞州健康信息系统数据,纳入42,279例2010至2014年新诊断的2型糖尿病患者和166,010名年龄性别匹配的无糖尿病对照。
- 按诊断年龄分为<50、50-59、60-69和≥70岁四组,采用以年龄为时间尺度的分层Cox比例风险回归模型估计HR和95%CI。
主要发现
- 中位随访9.20和9.32年期间,分别识别15,729例新发癌症病例和5,383例癌症死亡。
- 诊断年龄<50岁组总体癌症发病HR为1.35(95%CI 1.20, 1.52),胃肠道癌症发病HR为1.39(95%CI 1.11, 1.73)。
- 诊断年龄<50岁组总体癌症死亡HR为2.02(95%CI 1.50, 2.71),胃肠道癌症死亡HR为2.82(95%CI 1.91, 4.18)。
- 风险估计随诊断年龄每增加10岁而逐渐降低。
- 总体癌症和胃肠道癌症死亡的人群归因分数也随年龄增加而降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The age-specific associations between type 2 diabetes and cancer risk are not fully understood. The aim of this study was to assess how age at diagnosis modifies the associations between type 2 diabetes and cancer risk. METHODS: We used data from the Yinzhou Health Information System, and included 42,279 individuals who were newly diagnosed with type 2 diabetes between 2010 and 2014, as well as 166,010 age- and sex-matched control individuals without diabetes who were selected randomly from the electronic health records of the entire population. Patients were divided into four age groups according to age at diagnosis: <50, 50-59, 60-69 and ≥70 years. Stratified Cox proportional hazards regression models, with age as the time scale, were used to estimate the HRs and 95% CIs for the associations of type 2 diabetes with the risks of overall and site-specific cancers. Population-attributable fractions were also calculated for outcomes associated with type 2 diabetes. RESULTS: During median follow-up periods of 9.20 and 9.32 years, we identified 15,729 incident cancer cases and 5383 cancer deaths, respectively. Patients diagnosed with type 2 diabetes before 50 years of age had the highest relative risks of cancer incidence and mortality, with HRs (95% CI) of 1.35 (1.20, 1.52) for overall cancer incidence, 1.39 (1.11, 1.73) for gastrointestinal cancer incidence, 2.02 (1.50, 2.71) for overall cancer mortality, and 2.82 (1.91, 4.18) for gastrointestinal cancer mortality. Risk estimates decreased gradually with each decade increase in diagnostic age. The population-attributable fractions for overall cancer and gastrointestinal cancer mortality also decreased with increasing age. CONCLUSIONS/INTERPRETATION: The associations of type 2 diabetes with cancer incidence and mortality varied by age at diagnosis, with a higher relative risk among patients who were diagnosed at a younger age.
引用
- Yang Z, Wu Y, Xu L, et al. Age at diagnosis modifies associations of type 2 diabetes with cancer incidence and mortality: a retrospective matched-cohort study. Diabetologia. 2023. PMID: 37178138. doi:10.1007/s00125-023-05920-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。